STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Xencor, a clinical-stage biopharmaceutical company focusing on engineered monoclonal antibodies and cytokines for cancer and autoimmune diseases, announced that its CEO, Bassil Dahiyat, will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Virtual Conference. The event is set for May 19, 2021, at 1:20 p.m. ET. Investors can access a live webcast on the company's website, with a replay available for 30 days afterward. Xencor has 21 clinical candidates utilizing its XmAb technology.

Positive
  • None.
Negative
  • None.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will participate in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 19, 2021 at 1:20 p.m. ET / 10:20 a.m. PT.

A live webcast will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Following the webcast, a replay will be archived on the website for at least 30 days.

About Xencor, Inc.

Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. Currently, 21 candidates engineered with Xencor's XmAb® technology are in clinical development internally and with partners. Xencor's XmAb antibody engineering technology enables small changes to the structure of proteins resulting in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.

FAQ

What is Xencor's involvement in the 2021 RBC Capital Markets Global Healthcare Virtual Conference?

Xencor's CEO, Bassil Dahiyat, will participate in a virtual fireside chat on May 19, 2021.

When is the Xencor fireside chat scheduled?

The Xencor fireside chat is scheduled for May 19, 2021, at 1:20 p.m. ET.

Where can I watch the Xencor conference webcast?

The Xencor conference webcast can be accessed under 'Events & Presentations' in the Investors section on their website.

How long will the Xencor conference replay be available?

The replay of the Xencor conference will be available for at least 30 days.

What technologies does Xencor utilize in its development?

Xencor utilizes its XmAb technology to develop engineered monoclonal antibodies and cytokines.

Xencor, Inc.

NASDAQ:XNCR

XNCR Rankings

XNCR Latest News

XNCR Stock Data

1.80B
68.82M
0.87%
104.55%
7.16%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PASADENA